In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cutera's IPO: Will Others Follow?

Executive Summary

In the first four-plus months of 2004, there have been two medical device IPOs, compared to zero last year. Yet while a couple of companies does not a trend make, nevertheless, five more device hopefuls in the queue are cautiously optimistic that public investors are beginning to back at least certain kinds of medical device companies. But which kinds? Cutera Inc. raised $45.6 million in its IPO the last day of March [See Deal]. You could say that the company has made a strong start in an enormous, underpenetrated device market, and one that doesn't suffer from reimbursement risk-the consumer market for cosmetic procedures. But Cutera isn't just a story stock; it's a company with a record of predictably ramping up sales and earnings.


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts